Results 51 to 60 of about 837,328 (317)
Management of cardiogenic shock: a narrative review
Annals of Intensive CareCardiogenic shock (CS) is characterized by low cardiac output and sustained tissue hypoperfusion that may result in end-organ dysfunction and death. CS is associated with high short-term mortality, and its management remains challenging despite recent ...
D. Laghlam +6 more
semanticscholar +1 more source
Cardiogenic shock among cancer patients
Frontiers in Cardiovascular Medicine, 2022 Sophisticated cancer treatments, cardiovascular risk factors, and aging trigger acute cardiovascular diseases in an increasing number of cancer patients.
Anais Curtiaud +9 more
doaj +1 more source
Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2021 Background There is a lack of contemporary data on cardiogenic shock (CS) in‐hospital mortality trends. Methods and Results Patients with CS admitted January 1, 2004 to December 31, 2018, were identified from the US National Inpatient Sample. We reported
M. Osman +8 more
semanticscholar +1 more source
Efficiency of Renal Replacement Therapy for Cardiogenic Shock Complicated by Multiorgan Dysfunction
Общая реаниматология, 2011 Objective: to analyze the efficiency of renal replacement therapy (RRT) for acute myocardial infarction complicated by cardiogenic shock and multiorgan dysfunction. Subjects and methods.
L. S. Barbarash +5 more
doaj +1 more source
European Journal of Heart Failure, Volume 24, Issue 11, Page 2078-2089, November 2022., 2022 Aims To assess adherence to guideline recommendations among a large network of Italian cardiology sites in the management of acute and chronic heart failure (HF) and to evaluate if an ad‐hoc educational intervention can improve their performance on several pharmacological and non‐pharmacological indicators.
Michele Massimo Gulizia +197 more
wiley +1 more source
Laboratory Predictors of Prognosis in Cardiogenic Shock Complicating Acute Myocardial Infarction
Biomedicines, 2022 Cardiogenic shock is a state of reduced cardiac output leading to hypotension, pulmonary congestion, and hypoperfusion of tissues and vital organs. Despite the advances in intensive care over the last years, the morbidity and mortality of patients remain
Tamilla Muzafarova, Zuzana Motovska
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2021 Cardiogenic shock accounts for ~100,000 annual hospital admissions in the United States. Despite improvements in medical management strategies, in-hospital mortality remains unacceptably high.
A. Tsangaris +6 more
semanticscholar +1 more source
European Journal of Heart Failure, Volume 24, Issue 11, Page 2000-2018, November 2022., 2022 Overview on incidence, diagnosis, and therapy in vaccine‐related myocarditis. CMR, cardiac magnetic resonance; EMB, endomyocardial biopsy; NSAIDS, non‐steroidal anti‐inflammatory drugs. Abstract Over 10 million doses of COVID‐19 vaccines based on RNA technology, viral vectors, recombinant protein, and inactivated virus have been administered worldwide.
Bettina Heidecker +17 more
wiley +1 more source
Circulation, 2017 Cardiogenic shock is a high-acuity, potentially complex, and hemodynamically diverse state of end-organ hypoperfusion that is frequently associated with multisystem organ failure.
Sean van Diepen +12 more
semanticscholar +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Intravascular ultrasound (IVUS)‐guided optimization of suboptimal fractional flow reserve (FFR) following percutaneous coronary intervention (PCI) results in a significant increase in both post‐PCI FFR and minimal lumen and stent areas (MLA and MSA, respectively).
Frederik T. W. Groenland +9 more
wiley +1 more source